Islam Md Saimul, Chakraborty Balarko, Panda Chinmay Kumar
Department of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India.
Ann Transl Med. 2020 May;8(10):650. doi: 10.21037/atm-19-2756.
Breast cancer (BC) is frequent among women in worldwide as well as in India. Several studies have reported a wide variation (1.6-86.2%) in the frequency of incidence of human papillomavirus (HPV) infection in BC with high prevalence of high risk HPV16 subtype. HPV infection in breast can occur through different routes like body fluid or by micro-lesion of breast skin from genital/agential sites, though the actual mode of HPV transmission is not yet known in details. Frequent integration and sequence variation with low copy number of HPV16 were seen in this tumour. In addition, high frequencies of methylation in p97 promoter region of HPV16 were evident in this tumour. Novel splice variants of E6/E7 along with other common variants and their protein expression were seen in the tumour. This indicates the importance of HPV in this tumor, its early diagnosis and prognosis. Thus, HPV may be targeted through vaccination to control the disease. However, detailed analysis of HPV associated molecular pathogenesis of BC is warranted for proper therapeutic intervention.
乳腺癌(BC)在全球以及印度的女性中都很常见。多项研究报告称,乳腺癌中人类乳头瘤病毒(HPV)感染的发生率差异很大(1.6%-86.2%),其中高危HPV16亚型的患病率很高。乳房中的HPV感染可通过不同途径发生,如体液传播或通过生殖器/肛门部位的乳房皮肤微损伤传播,不过HPV实际的传播方式尚不清楚。在这种肿瘤中,可见HPV16频繁整合且拷贝数低的序列变异。此外,该肿瘤中HPV16的p97启动子区域甲基化频率很高。在肿瘤中发现了E6/E7的新型剪接变体以及其他常见变体及其蛋白表达。这表明HPV在该肿瘤、其早期诊断和预后中的重要性。因此,可通过接种疫苗针对HPV来控制该疾病。然而,为了进行适当的治疗干预,有必要对BC中HPV相关的分子发病机制进行详细分析。